SS-INQ Information Needs Questionnaire in Sjögren's Syndrome
SS-INQ
Defining the Informational Needs of Patients With Sjögren's Syndrome and Development of a Sjögren's Syndrome-specific Informational Needs Questionnaire (SS-INQ)
1 other identifier
observational
243
1 country
1
Brief Summary
Patients with some long-standing rheumatic diseases have stated that they want to be fully informed about their disease as they find it 'more scary not to know' about possible complications and consequences. Patients who have the information they want about their disease can fully take part in decisions about their own health creating a partnership with their doctor. Sjögren's Syndrome (SS) is a multi-system, long-standing rheumatic disease that has a negative impact on the daily life of patients. A common presentation of this disease is dry mouth, which can make talking, eating and swallowing more difficult. Project aims: We aim to ask patients with SS what information they think it would be important to know about SS. We plan to create a questionnaire that can be used by doctors to help deliver the right information to patients at hospital visits. Timescale: This project will take 36 months to complete. Clinical relevance: This questionnaire could be used in daily practice. It could help patients cope with their disease, take part in treatment decision and reduced uncertainty and distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2018
CompletedFirst Submitted
Initial submission to the registry
March 5, 2021
CompletedFirst Posted
Study publicly available on registry
March 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2021
CompletedOctober 12, 2021
March 1, 2021
2.8 years
March 5, 2021
October 11, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Determine information needs of patients with SS and develop a new questionnaire
Qualitative interviews with patients with SS Interview transcriptions and thematic analysis Adaptation of TINQ-BC for use in patients with SS - generation of relevant questions using themes from Phase 1 qualitative study (removal of those solely related to breast cancer from TINQ-BC) by the expert group Pilot testing of SS-INQ for content and readability will be done via focus groups whilst structural validity will be explored using factor analysis Testing of SS-INQ for reliability - internal consistency reliability and test-retest reliability
3 years
Study Arms (2)
Observational - phase 1
Determination of Informational Needs (Months 0- 9) * Qualitative interviews with patients with SS * Interview transcriptions and thematic analysis
Observational - phase 2
Phase 2 Development of the informational need instrument for SS \[SS-INQ\] (Months 9-32) * Adaptation of TINQ-BC for use in patients with SS - generation of relevant questions using themes from Phase 1 qualitative study (removal of those solely related to breast cancer from TINQ-BC) by the expert group * Pilot testing of SS-INQ for content and readability will be done via focus groups whilst structural validity will be explored using factor analysis * Testing of SS-INQ for reliability - internal consistency reliability and test-retest reliability
Interventions
Qualitative interviews with patients with SS
Eligibility Criteria
Sjögren's Syndrome above 18 years old.
You may qualify if:
- Adult patients with a diagnosis of primary SS as per the 2002 American-European Consensus Group (AECG) classification criteria, or
- Adult patients with a diagnosis of primary SS as per the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria
- Adults with the capacity to consent to their involvement in the study
- Willingness to participate in focus groups
- Fluency in the English language to allow participation in focus group discussion
- Willingness to complete the newly developed questionnaire on at least on occasion
You may not qualify if:
- Patients with SS who have developed lymphomatous chang
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College London Hospitals NHS Foundation Trust
London, NW1 2BU, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2021
First Posted
March 15, 2021
Study Start
October 12, 2018
Primary Completion
July 21, 2021
Study Completion
July 21, 2021
Last Updated
October 12, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share